v3.25.1
Consolidated Balance Sheets - ILS (₪)
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and Cash Equivalents ₪ 54,731 ₪ 135,832
Short term Investments 3,902 3,030
Trade and Other Account Receivables 55,762 44,460
Loans Granted 474,950 551,463
Total Current Assets 589,345 734,785
Intangible Assets and Fixed Assets 62,500 1,419
Investment and advances in account of Investment 80,000 205,000
Long Term Loans Granted 47,752
Total non-current assets 142,500 254,171
Total Assets 731,845 988,956
Current Liabilities    
Short term loans from Banking Institutions 16,622
Trade payables 18,104 14,505
Other accounts payables 987,627 532,437
Total Current Liabilities 3,351,779 2,850,674
Shareholders’ Deficit    
Convertible preferred stock, NIS 0.01 par value 10,000,000 shares authorized, issued and outstanding as of December 31, 2024 and 2023. 100,000 100,000
Common stock, NIS 0.01 par value 990,000,000 share authorized; 2,282,124 issued and outstanding shares as of December 31, 2024 and 2023. 22,821 22,821
Additional paid-in capital 1,049,703 1,049,703
Accumulated Deficit (3,792,458) (3,034,242)
Total Shareholders’ Deficit (2,619,934) (1,861,718)
Total Liabilities and Shareholders’ Deficit 731,845 988,956
Related Party    
Current Liabilities    
Loans from related parties (see Note 15) ₪ 2,346,048 ₪ 2,287,110